To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Immune activation of the … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.

Journal article
Authors Arvid Edén
Richard W Price
Serena Spudich
Dietmar Fuchs
Lars Hagberg
Magnus Gisslén
Published in The Journal of infectious diseases
Volume 196
Issue 12
Pages 1779-83
ISSN 0022-1899
Publication year 2007
Published at Institute of Biomedicine, Department of Infectious Medicine
Pages 1779-83
Language en
Keywords Adult, Antiretroviral Therapy, Highly Active, methods, Central Nervous System, drug effects, immunology, pathology, HIV Infections, blood, cerebrospinal fluid, drug therapy, immunology, HIV-1, genetics, isolation & purification, Humans, Immunoglobulin G, blood, cerebrospinal fluid, Leukocyte Count, Middle Aged, Neopterin, blood, cerebrospinal fluid, RNA, Viral, blood, cerebrospinal fluid, Retrospective Studies
Subject categories Infectious Medicine


Highly active antiretroviral therapy (HAART) effectively reduces human immunodeficiency virus (HIV) RNA in cerebrospinal fluid (CSF), as well as in plasma. The effect on intrathecal immunoactivation is less well studied. We had earlier found that a substantial number of patients still have evidence of intrathecal immunoactivation after up to 2 years of treatment. We identified 15 patients treated with HAART for > or =4 years who had plasma HIV-RNA levels of <50 copies/mL for > or =3.5 years. CSF samples were available from 10 patients before treatment. We measured white-blood-cell count, HIV-RNA level, neopterin level, and IgG index. During treatment, all patients had HIV-RNA levels of <50 copies/mL in plasma and CSF. In CSF, both neopterin level and IgG index decreased significantly. After 4 years, 9 (60%) of the 15 patients still had neopterin levels in CSF that were above the upper normal reference value (5.8 nmol/L). During HAART, 9 (60%) of the 15 patients had an abnormal IgG index (>0.63). HAART significantly decreases intrathecal immunoactivation, but, despite effective treatment for >4 years, with HIV-RNA levels <50 copies/mL for > or =3.5 years, a substantial proportion of patients continue to show signs of macrophage/microglia activation and intrathecal immunoglobulin production in the CNS.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?